Procter & Gamble stock
Price history
+14.76% over the period1 year: from $147.96 (November 13, 2025) to $169.80 (November 13, 2026), +14.76%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 13, 2026 | $169.80 |
| October 30, 2026 | $161.57 |
| September 30, 2026 | $145.28 |
| August 31, 2026 | $145.12 |
| July 31, 2026 | $144.49 |
| June 30, 2026 | $146.64 |
| May 29, 2026 | $143.56 |
| April 30, 2026 | $147.09 |
| March 31, 2026 | $144.44 |
| February 27, 2026 | $167.20 |
| January 30, 2026 | $151.77 |
| December 31, 2025 | $143.31 |
| November 28, 2025 | $148.16 |
| November 13, 2025 | $147.96 |
At a glance
The company
Produce branded consumer packaged goods including beauty, grooming, health care, fabric care and baby care products
Latest results
Quarter to September 30, 2026 · EPS $2.00 (estimate $1.88)
Next event
TickerLandia's take on Procter & Gamble
- Priced as usual relative to earnings: P/E on the latest fiscal year 26 vs a median of 25 over its last 10 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 26 vs 26 (+0%) in a group of 11.
- Strong point: Market momentum (75/100 in its group). Weak point: Financial strength (39/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−0.54% from the 52-week high
Analysts · 25 analysts
Average target$174.04+2.50% vs. price
Buy 14 · Hold 10 · Sell 1 · Buy
TickerLandia Fingerprint: Procter & Gamble
Compared with similar companies: very low risk.
Financials and price compared with 27 companies in the household & personal products industry, worldwide. Momentum and risk compared with 883 North American stocks.
Pricehigh71
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 25.6 56 Forward P/E 23.0 71 EV/EBITDA 16.7 72 Price/book 7.24 67 Price/sales 4.48 87 Profitabilityhigh74
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 24.9% 94 ROE 29.6% 69 ROA 10.5% 80 Gross margin 50.6% 50 Net margin 18.2% 76 Earnings stabilityhigh69
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.9% 80 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 57 Growthaverage51
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +2.00% 50 Earnings growth (year over year) +0.80% 46 Revenue growth (year over year) +4.00% 57 Financial strengthlow39
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 0.82 43 Interest coverage 24.6 69 Debt/equitycounts in reverse: lower means more financial strength 0.70 35 Current ratio 0.72 9 Dividendhigh65
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 37 years 91 Dividend yield 2.6% 54 Payout ratio 65.1% 50 Market momentumstrong75
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +21.40% 93 1-year return +14.76% 53 Distance from 200-day average +13.29% 77 Relative strength (6 months) +17.52% 76 Riskvery low13
How much the price swings.
Metric Value Position in group Volatility (60 days) 21.2% 13 Beta (1 year) −0.03 15 Maximum drawdown (12 months) 16.2% 13
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Procter & Gamble is priced as in the past and in line with similar companies
On the latest fiscal year's earnings (2026), Procter & Gamble's P/E today is 25.6, in line with the median of its last 10 fiscal years (24.5; between 15.6 and 76.7 from 2017 to 2026). Procter & Gamble's P/E (trailing 12 months): 25.6, in line with the median of a group of 11 similar companies (25.6).
Compared with 11 similar companies
| Metric | Procter & Gamble | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 25.6 | Middle | |
| Forward P/E | 23.0 | Middle | |
| Operating margin | 24.9% | High | |
| ROE | 29.6% | Middle | |
| Debt/equity | 0.70 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Procter & Gamble. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$23.28B
Latest quarter · Q3 2026
Net income
$4.73B
Latest quarter · Q3 2026
Quarterly net margin
20.3%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $393.56B
- P/E
- 25.6
- EPS
- $6.64
- Volume
- 6.94M
- Daily trading
- €1.49B
- Dividend yield
- 2.55%
- Last ex-dividend on October 23, 2026
How Procter & Gamble is changing
All resultsRevenue grew 2.7% a year on average over the last 5 years
Profits turn into cash: free cash flow equal to 97% of net income
Shares outstanding down 6.9% in 5 years
Returns
Procter & Gamble returns with dividends
$1,000 invested in Procter & Gamble 5 years ago, on November 15, 2021, would be worth $1,310 today with dividends reinvested: +31.04% in total, +5.56% per year. On price alone it would be $1,152 (+15.20%).
| Period | Procter & Gamble | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +10.95% | −3.12% | $1,110 |
| 6 months | +19.38% | +1.58% | $1,194 |
| Year to date | +18.48% | +10.46% | $1,185 |
| 1 year | +18.07% | +12.23% | $1,181 |
| 3 years | +20.55% | +71.41% | $1,205 |
| 5 years | +31.04% | +61.48% | $1,310 |
| 10 years | +168.50% | +249.40% | $2,685 |
Over the last 6 months it has done better than 75% of the stocks in the Consumer sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Procter & Gamble: technical analysis
Procter & Gamble is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 5.5% below its highest close since January 2, 1990 ($179.70, December 2, 2024).
- Trend
- Upward
- RSI (14 sessions)
- 68
- Between 30 and 70
- vs 200-session average
- +13.29%
Active signals
New 52-week high.
Support and resistance
Price areas where Procter & Gamble has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last price$169.80
- Support$167.05−1.62%2 touches, last on October 22, 2026
- Support$153.13−9.82%6 touches, last on July 28, 2026
- Support$148.15−12.75%7 touches, last on September 28, 2026
Volatility and risk
Over the last year it has moved little with the S&P 500.
- Beta (1 year) vs S&P 500
- −0.03
- Volatility (60 sessions, annualised)
- 21.2%
- Largest fall in the last year
- −16.15%
Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Procter & Gamble: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Procter & Gamble has been October: +2.91% on average, positive in 24 years out of 37. The weakest has been January: −0.86% on average, positive in 16 years out of 36. November, the current month, has been positive in 24 years out of 36 (+2.56% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.86% | −0.45% | 16 of 36 |
| February | −0.18% | +1.00% | 19 of 37 |
| March | −0.50% | −0.17% | 17 of 37 |
| April | +0.67% | +0.87% | 21 of 37 |
| May | +0.95% | +0.82% | 19 of 37 |
| June | −0.79% | −0.28% | 16 of 37 |
| July | +1.63% | +1.09% | 22 of 37 |
| August | +1.37% | +1.60% | 22 of 37 |
| September | +0.90% | +0.48% | 22 of 37 |
| October | +2.91% | +2.27% | 24 of 37 |
| November | +2.56% | +2.46% | 24 of 36 |
| December | +1.37% | +1.53% | 23 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Procter & Gamble and its competitors
Branded consumer packaged goods sold worldwide form the core of The Procter & Gamble Company's business, organized into five segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. Its brands include Pantene, Gillette, Crest, Tide, Pampers and Always, sold through mass merchandisers, grocery and drug stores, pharmacies, membership clubs, professional channels and directly to consumers.
- Headquarters
- Cincinnati, United States
- Employees
- 104,000
- Founded
- 1837
- Chief executive
- Shailesh Jejurikar
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Procter & GamblePG | $393.56B | 24.9% | 25.6 | +19.38% |
| Colgate-PalmoliveCL | $79.23B | 20.7% | 38.8 | +13.43% |
| Kimberly-ClarkKMB | $67.15B | 17.3% | 20.9 | +12.77% |
| Estée Lauder CompaniesEL | $40.49B | 11.9% | 111.8 | +36.06% |
| KenvueKVUE | $37.11B | 19.2% | 21.9 | +10.15% |
| Church And DwightCHD | $26.67B | 18.6% | 34.7 | +18.83% |
Same industry or related industries, similar size. Compare Procter & Gamble with its competitors · Full profile
